RUNX3 and glioma: Majchrzak-Celińska and colleagues showed RUNX3 promoter methylation changes in different grade gliomas where methylation frequency was consistently increasing along with glioma grade, 0%; 22%; 52%; 62.5%, grades I; II; III; IV, respectively.